ID

38065

Descripción

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor; ODM derived from: https://clinicaltrials.gov/show/NCT01610284

Link

https://clinicaltrials.gov/show/NCT01610284

Palabras clave

Versiones (1)
  1. 14/9/19 14/9/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

14 de septiembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT01610284

Inglés

Eligibility Breast Cancer NCT01610284

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
locally advanced or metastatic breast cancer
Descripción

Locally advanced breast cancer | Secondary malignant neoplasm of female breast

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3495949
UMLS CUI [2]
C0346993
her2-negative and hormone receptor-positive status (common breast cancer classification tests)
Descripción

HER2 Negative | Hormone Receptor Positive | Breast Carcinoma Classification Tests

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348908
UMLS CUI [2,1]
C0019929
UMLS CUI [2,2]
C1514241
UMLS CUI [3,1]
C0678222
UMLS CUI [3,2]
C0008902
UMLS CUI [3,3]
C0392366
postmenopausal woman
Descripción

Postmenopausal state

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
a tumor sample must be shipped to a novartis designated laboratory for identification of biomarkers (pi3k activation status)
Descripción

Availability of Tumor tissue sample | Biomarker Identification | PI-3K Activation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C0475358
UMLS CUI [2,1]
C0005516
UMLS CUI [2,2]
C0205396
UMLS CUI [3,1]
C2936824
UMLS CUI [3,2]
C1879547
progression or recurrence of breast cancer while on or after aromatase inhibitor treatment
Descripción

Progression Breast Carcinoma | Breast cancer recurrent | Aromatase Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0449258
UMLS CUI [1,2]
C0678222
UMLS CUI [2]
C0278493
UMLS CUI [3]
C0593802
measurable disease or non measurable disease bone lesions in the absence of measurable disease as per recist 1.1
Descripción

Measurable Disease | Non-Measurable Lesion | Bone lesion Measurable Disease Absent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1334988
UMLS CUI [3,1]
C0238792
UMLS CUI [3,2]
C1513041
UMLS CUI [3,3]
C0332197
adequate bone marrow and organ function defined by laboratory values
Descripción

Bone Marrow function Definition Laboratory Results | Organ function Definition Laboratory Results

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [1,3]
C1704788
UMLS CUI [1,4]
C1254595
UMLS CUI [2,1]
C0678852
UMLS CUI [2,2]
C1704788
UMLS CUI [2,3]
C1254595
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with pi3k inhibitors, akt inhibitors, mtor inhibitor or fulvestrant
Descripción

Prior Therapy | PI3K Inhibitor | AKT inhibitors | mTOR Inhibitors | fulvestrant

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514463
UMLS CUI [2]
C1519050
UMLS CUI [3,1]
C0812228
UMLS CUI [3,2]
C0243077
UMLS CUI [4]
C1515672
UMLS CUI [5]
C0935916
more than one prior chemotherapy line for metastatic disease
Descripción

Prior Chemotherapy Quantity Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
symptomatic brain metastases
Descripción

Metastatic malignant neoplasm to brain Symptomatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0231220
increasing or chronic treatment (> 5 days) with corticosteroids or another immunosuppressive agent
Descripción

Adrenal Cortex Hormones Increasing | Adrenal Cortex Hormones chronic | Immunosuppressive Agents Increasing | Immunosuppressive Agents chronic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0442808
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C0205191
UMLS CUI [3,1]
C0021081
UMLS CUI [3,2]
C0442808
UMLS CUI [4,1]
C0021081
UMLS CUI [4,2]
C0205191
active heart (cardiac) disease as defined in the protocol
Descripción

Heart Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018799
certain scores on an anxiety and depression mood questionnaires
Descripción

Anxiety Questionnaire Score | Depressed mood Questionnaire Score

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003467
UMLS CUI [1,2]
C0034394
UMLS CUI [1,3]
C0449820
UMLS CUI [2,1]
C0344315
UMLS CUI [2,2]
C0034394
UMLS CUI [2,3]
C0449820
other protocol-defined inclusion/exclusion criteria may apply
Descripción

Eligibility Criteria Study Protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT01610284

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Locally advanced breast cancer | Secondary malignant neoplasm of female breast
Item
locally advanced or metastatic breast cancer
boolean
C3495949 (UMLS CUI [1])
C0346993 (UMLS CUI [2])
HER2 Negative | Hormone Receptor Positive | Breast Carcinoma Classification Tests
Item
her2-negative and hormone receptor-positive status (common breast cancer classification tests)
boolean
C2348908 (UMLS CUI [1])
C0019929 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0678222 (UMLS CUI [3,1])
C0008902 (UMLS CUI [3,2])
C0392366 (UMLS CUI [3,3])
Postmenopausal state
Item
postmenopausal woman
boolean
C0232970 (UMLS CUI [1])
Availability of Tumor tissue sample | Biomarker Identification | PI-3K Activation
Item
a tumor sample must be shipped to a novartis designated laboratory for identification of biomarkers (pi3k activation status)
boolean
C0470187 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
C0005516 (UMLS CUI [2,1])
C0205396 (UMLS CUI [2,2])
C2936824 (UMLS CUI [3,1])
C1879547 (UMLS CUI [3,2])
Progression Breast Carcinoma | Breast cancer recurrent | Aromatase Inhibitors
Item
progression or recurrence of breast cancer while on or after aromatase inhibitor treatment
boolean
C0449258 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0278493 (UMLS CUI [2])
C0593802 (UMLS CUI [3])
Measurable Disease | Non-Measurable Lesion | Bone lesion Measurable Disease Absent
Item
measurable disease or non measurable disease bone lesions in the absence of measurable disease as per recist 1.1
boolean
C1513041 (UMLS CUI [1])
C1334988 (UMLS CUI [2])
C0238792 (UMLS CUI [3,1])
C1513041 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
Bone Marrow function Definition Laboratory Results | Organ function Definition Laboratory Results
Item
adequate bone marrow and organ function defined by laboratory values
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C1704788 (UMLS CUI [1,3])
C1254595 (UMLS CUI [1,4])
C0678852 (UMLS CUI [2,1])
C1704788 (UMLS CUI [2,2])
C1254595 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Prior Therapy | PI3K Inhibitor | AKT inhibitors | mTOR Inhibitors | fulvestrant
Item
previous treatment with pi3k inhibitors, akt inhibitors, mtor inhibitor or fulvestrant
boolean
C1514463 (UMLS CUI [1])
C1519050 (UMLS CUI [2])
C0812228 (UMLS CUI [3,1])
C0243077 (UMLS CUI [3,2])
C1515672 (UMLS CUI [4])
C0935916 (UMLS CUI [5])
Prior Chemotherapy Quantity Neoplasm Metastasis
Item
more than one prior chemotherapy line for metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Metastatic malignant neoplasm to brain Symptomatic
Item
symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Adrenal Cortex Hormones Increasing | Adrenal Cortex Hormones chronic | Immunosuppressive Agents Increasing | Immunosuppressive Agents chronic
Item
increasing or chronic treatment (> 5 days) with corticosteroids or another immunosuppressive agent
boolean
C0001617 (UMLS CUI [1,1])
C0442808 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0021081 (UMLS CUI [3,1])
C0442808 (UMLS CUI [3,2])
C0021081 (UMLS CUI [4,1])
C0205191 (UMLS CUI [4,2])
Heart Disease
Item
active heart (cardiac) disease as defined in the protocol
boolean
C0018799 (UMLS CUI [1])
Anxiety Questionnaire Score | Depressed mood Questionnaire Score
Item
certain scores on an anxiety and depression mood questionnaires
boolean
C0003467 (UMLS CUI [1,1])
C0034394 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,3])
C0344315 (UMLS CUI [2,1])
C0034394 (UMLS CUI [2,2])
C0449820 (UMLS CUI [2,3])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial